It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Dental fees to jump in Japan as palladium prices surge on Ukraine war

National Apr 12, 2022

Dental fees to jump in Japan as palladium prices surge on Ukraine war

The change is expected to translate into a rise of several hundred yen in the cost for patients younger than 70 for each tooth treated with "silver" fillings.

We need better COVID-19 booster shots, not more of the same

Commentary / World Apr 11, 2022

We need better COVID-19 booster shots, not more of the same

by Faye Flam

There are 100 new Covid vaccines in development. One of them could offer better protection against omicron.

With a $2.1 million cure their only hope, Indian parents plead for help online

Asia Pacific Apr 10, 2022

With a $2.1 million cure their only hope, Indian parents plead for help online

by Sameer Yasir and Shalini Venugopal Bhagat

India makes many of the world’s drugs, but treatments for rare diseases like spinal muscular atrophy are imported and prohibitively costly.

Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug

Business Apr 9, 2022

Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug

The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.

Japan team proves iPS-based cornea transplants are safe in first clinical trial

National / Science & Health Apr 4, 2022

Japan team proves iPS-based cornea transplants are safe in first clinical trial

Three of the patients in the clinical trial experienced improved eyesight, with one improving from 0.15 to 0.7, the Osaka University team said.

Activist fund executives on board bolstered Olympus, CEO says

Business / Corporate Mar 28, 2022

Activist fund executives on board bolstered Olympus, CEO says

by Kanoko Matsuyama and Grace Huang

Olympus’s shares have more than doubled since ValueAct, a U.S. hedge fund, persuaded Olympus to accept its director nominations in 2019.

Second vaccine booster significantly lowers COVID-19 death rate: Israeli study

World / Science & Health Mar 27, 2022

Second vaccine booster significantly lowers COVID-19 death rate: Israeli study

Senior citizens who received a second booster of the Pfizer-BioNTech COVID-19 vaccination had a 78% lower mortality rate from the disease than those who got one only.

How long should it take to grieve? Psychiatry has come up with an answer.

Lifestyle Mar 27, 2022

How long should it take to grieve? Psychiatry has come up with an answer.

by Ellen Barry

Will categorizing prolonged grief as a mental disorder help people in need get access to crucial treatment or hurt those who simply take longer to overcome loss?

Drugmakers and scientists begin the hunt for long COVID treatments

World / Science & Health | FOCUS Mar 25, 2022

Drugmakers and scientists begin the hunt for long COVID treatments

by Jennifer Rigby and Julie Steenhuysen

Leading drugmakers, including those who have launched pills and monoclonal antibodies for COVID-19, are having early discussions with researchers about how to target the disease.

Japanese firms near domestic rollout of their COVID-19 vaccines

National | FOCUS Mar 15, 2022

Japanese firms near domestic rollout of their COVID-19 vaccines

by Osamu Tsukimori

Several companies are expecting to introduce their shots in the coming fiscal year, a major step in Japan reducing its reliance on foreign vaccine manufacturers.

Drugmakers pause trials in Russia while still sending medicine

Business Mar 15, 2022

Drugmakers pause trials in Russia while still sending medicine

by Riley Griffin and Robert Langreth

Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia’s invasion of Ukraine and the needs of sick patients.

China fires mayors and closes schools as COVID-19 outbreak spreads

Asia Pacific Mar 13, 2022

China fires mayors and closes schools as COVID-19 outbreak spreads

by Keith Bradsher

China’s National Health Commission announced Saturday that another 1,524 locally transmitted coronavirus cases had been detected in provinces across mainland China.

« 1 … 16 17 18 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times